Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They presently have a $40.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 123.34% from the stock’s previous close. Several other research […]

Lyell Immunopharma (NASDAQ:LYEL – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $45.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 265.56% from the stock’s previous close. A […]